List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Agomelatine Product Introduction
1.2 Market by Type
1.2.1 Global Agomelatine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Serotonin 2C Agonist
1.2.3 Melatonin Receptor 2 Agonist
1.2.4 Melatonin Receptor 1 Agonist
1.2.5 Serotonin Receptor Agonist
1.2.6 Serotonin 2C Receptor Antagonist
1.3 Market by Application
1.3.1 Global Agomelatine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Depression
1.3.3 Obsessive Compulsive Disorder
1.3.4 Sleep Disorders
1.3.5 Generalized Anxiety Disorder
1.3.6 Multiple Sclerosis
1.3.7 Systemic Traumatic Pain
1.3.8 Autism
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Agomelatine Sales Estimates and Forecasts 2017-2028
2.2 Global Agomelatine Revenue Estimates and Forecasts 2017-2028
2.3 Global Agomelatine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Agomelatine Sales by Region
2.4.1 Global Agomelatine Sales by Region (2017-2022)
2.4.2 Global Sales Agomelatine by Region (2023-2028)
2.5 Global Agomelatine Revenue by Region
2.5.1 Global Agomelatine Revenue by Region (2017-2022)
2.5.2 Global Agomelatine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Agomelatine Sales by Manufacturers
3.1.1 Global Top Agomelatine Manufacturers by Sales (2017-2022)
3.1.2 Global Agomelatine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Agomelatine in 2021
3.2 Global Agomelatine Revenue by Manufacturers
3.2.1 Global Agomelatine Revenue by Manufacturers (2017-2022)
3.2.2 Global Agomelatine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Agomelatine Revenue in 2021
3.3 Global Agomelatine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Agomelatine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Agomelatine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Agomelatine Sales by Type
4.1.1 Global Agomelatine Historical Sales by Type (2017-2022)
4.1.2 Global Agomelatine Forecasted Sales by Type (2023-2028)
4.1.3 Global Agomelatine Sales Market Share by Type (2017-2028)
4.2 Global Agomelatine Revenue by Type
4.2.1 Global Agomelatine Historical Revenue by Type (2017-2022)
4.2.2 Global Agomelatine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Agomelatine Revenue Market Share by Type (2017-2028)
4.3 Global Agomelatine Price by Type
4.3.1 Global Agomelatine Price by Type (2017-2022)
4.3.2 Global Agomelatine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Agomelatine Sales by Application
5.1.1 Global Agomelatine Historical Sales by Application (2017-2022)
5.1.2 Global Agomelatine Forecasted Sales by Application (2023-2028)
5.1.3 Global Agomelatine Sales Market Share by Application (2017-2028)
5.2 Global Agomelatine Revenue by Application
5.2.1 Global Agomelatine Historical Revenue by Application (2017-2022)
5.2.2 Global Agomelatine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Agomelatine Revenue Market Share by Application (2017-2028)
5.3 Global Agomelatine Price by Application
5.3.1 Global Agomelatine Price by Application (2017-2022)
5.3.2 Global Agomelatine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Agomelatine Market Size by Type
6.1.1 North America Agomelatine Sales by Type (2017-2028)
6.1.2 North America Agomelatine Revenue by Type (2017-2028)
6.2 North America Agomelatine Market Size by Application
6.2.1 North America Agomelatine Sales by Application (2017-2028)
6.2.2 North America Agomelatine Revenue by Application (2017-2028)
6.3 North America Agomelatine Market Size by Country
6.3.1 North America Agomelatine Sales by Country (2017-2028)
6.3.2 North America Agomelatine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Agomelatine Market Size by Type
7.1.1 Europe Agomelatine Sales by Type (2017-2028)
7.1.2 Europe Agomelatine Revenue by Type (2017-2028)
7.2 Europe Agomelatine Market Size by Application
7.2.1 Europe Agomelatine Sales by Application (2017-2028)
7.2.2 Europe Agomelatine Revenue by Application (2017-2028)
7.3 Europe Agomelatine Market Size by Country
7.3.1 Europe Agomelatine Sales by Country (2017-2028)
7.3.2 Europe Agomelatine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Agomelatine Market Size by Type
8.1.1 Asia Pacific Agomelatine Sales by Type (2017-2028)
8.1.2 Asia Pacific Agomelatine Revenue by Type (2017-2028)
8.2 Asia Pacific Agomelatine Market Size by Application
8.2.1 Asia Pacific Agomelatine Sales by Application (2017-2028)
8.2.2 Asia Pacific Agomelatine Revenue by Application (2017-2028)
8.3 Asia Pacific Agomelatine Market Size by Region
8.3.1 Asia Pacific Agomelatine Sales by Region (2017-2028)
8.3.2 Asia Pacific Agomelatine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Agomelatine Market Size by Type
9.1.1 Latin America Agomelatine Sales by Type (2017-2028)
9.1.2 Latin America Agomelatine Revenue by Type (2017-2028)
9.2 Latin America Agomelatine Market Size by Application
9.2.1 Latin America Agomelatine Sales by Application (2017-2028)
9.2.2 Latin America Agomelatine Revenue by Application (2017-2028)
9.3 Latin America Agomelatine Market Size by Country
9.3.1 Latin America Agomelatine Sales by Country (2017-2028)
9.3.2 Latin America Agomelatine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Agomelatine Market Size by Type
10.1.1 Middle East and Africa Agomelatine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Agomelatine Revenue by Type (2017-2028)
10.2 Middle East and Africa Agomelatine Market Size by Application
10.2.1 Middle East and Africa Agomelatine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Agomelatine Revenue by Application (2017-2028)
10.3 Middle East and Africa Agomelatine Market Size by Country
10.3.1 Middle East and Africa Agomelatine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Agomelatine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Servier
11.1.1 Servier Corporation Information
11.1.2 Servier Overview
11.1.3 Servier Agomelatine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Servier Agomelatine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Servier Recent Developments
11.2 Rovi Pharma
11.2.1 Rovi Pharma Corporation Information
11.2.2 Rovi Pharma Overview
11.2.3 Rovi Pharma Agomelatine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Rovi Pharma Agomelatine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Rovi Pharma Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Agomelatine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Agomelatine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Nectid Inc
11.4.1 Nectid Inc Corporation Information
11.4.2 Nectid Inc Overview
11.4.3 Nectid Inc Agomelatine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nectid Inc Agomelatine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nectid Inc Recent Developments
11.5 Jiangsu Haosen Pharmaceutical Group
11.5.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
11.5.2 Jiangsu Haosen Pharmaceutical Group Overview
11.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jiangsu Haosen Pharmaceutical Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Agomelatine Industry Chain Analysis
12.2 Agomelatine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Agomelatine Production Mode & Process
12.4 Agomelatine Sales and Marketing
12.4.1 Agomelatine Sales Channels
12.4.2 Agomelatine Distributors
12.5 Agomelatine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Agomelatine Industry Trends
13.2 Agomelatine Market Drivers
13.3 Agomelatine Market Challenges
13.4 Agomelatine Market Restraints
14 Key Findings in The Global Agomelatine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
